IgG reactive with the p40 protein encoded by the LINE-1 retroelement.

Clicks: 372
ID: 62713
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #6 of 8 articles by views in arthritis & rheumatology (hoboken, nj)

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The nature and specificity of the self-antigens targeted by autoantibodies characteristic of systemic autoimmune diseases can suggest clues to mechanisms initiating disease. In systemic lupus erythematosus (SLE), anti-double stranded DNA autoantibodies are features of active disease and are particularly associated with lupus nephritis, and the identity of the self or foreign antigens that "break tolerance", leading to anti-dsDNA and other autoantibody specificities, has been a topic of extensive study. In that context, the studies published by Carter et al (1) identifying reactivity of sera from SLE patients with the 40 kD protein product of the first open-reading frame (ORF) of the human LINE-1 (L1) retroelement are of great interest. This article is protected by copyright. All rights reserved.
Reference Key
crow2019iggarthritis Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Crow, Mary K;
Journal arthritis & rheumatology (hoboken, nj)
Year 2019
DOI
10.1002/art.41102
URL
Keywords
rad sequencing bufonidae green toads allopolyploidization cryptic species hybrid speciation

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.